Central labs receive 300 cough syrup samples

NEW DELHI : Government laboratories have received around 300 cough syrup samples for quality testing after the embarrassment of toxic syrups causing deaths abroad.

Indian-made cough syrups have been linked to the death of dozens of children in Uzbekistan and Gambia, prompting the government to tighten the export policy for cough syrups. It is now mandatory to test before supplying to other countries.

As of 4 July, Central labs in Chennai, Mumbai, Kolkata, Ghaziabad (UP), Chandigarh, Gujarat and Jammu had received samples.

On the other hand, government labs in Karnataka, Kerala, Bhopal, Maharashtra, and Uttarakhand, Hyderabad and Guwahati are yet to receive any. The drug regulator has issued an alert to all manufacturers not to over-burden one particular lab for testing.

India, the largest provider of generic drugs globally, exported cough syrups worth $17.6 billion in 2022-23 as against $17 billion in 2021-22. India’s pharma export body Pharmexcil has over 2,000 manufacturers registered with it, and most are manufacturing cough syrups. Queries sent to the health ministry spokesperson did not elicit any response.

Related Posts

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

Mumbai: On Tuesday, the FDA said it had sealed a cosmetic manufacturing factory in Bhiwandi for allegedly misleading consumers on e-commerce platforms by labelling its products as sulfate-free and paraben-free. The stock…

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

Justice Sumeet Goel made it clear that having licences or running a registered business did not automatically protect an accused, if the material on record pointed to possible illegal activity…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

No cough syrups without a doctor’s prescription – New rules announced

No cough syrups without a doctor’s prescription – New rules announced

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death